CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 136 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $24,000 | -17.2% | 10,350 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $29,000 | +61.1% | 10,350 | +36.2% | 0.00% | 0.0% |
| Q3 2017 | $18,000 | -5.3% | 7,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $19,000 | -29.6% | 7,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $27,000 | -87.7% | 7,600 | -3.2% | 0.00% | -92.9% |
| Q1 2015 | $219,000 | -13.4% | 7,854 | +9.9% | 0.01% | -41.7% |
| Q3 2013 | $253,000 | – | 7,149 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |